Prostate artery embolization (PAE) is a minimally invasive procedure that shrinks an enlarged prostate by cutting off its blood supply. A specialist threads a thin catheter through an artery, guides it to the vessels feeding the prostate, and injects tiny particles that block blood flow. Without that supply, the excess prostate tissue dies off and the gland gradually shrinks over the following weeks, relieving the urinary symptoms caused by benign prostatic hyperplasia (BPH). It’s performed without general anesthesia, typically as an outpatient procedure, and most patients return to normal activities the next day.
How It Works
The prostate depends on a network of small arteries for its blood supply. During PAE, an interventional radiologist inserts a catheter, usually through the femoral artery in the groin (though wrist access is also used), and navigates it under imaging guidance to the prostatic arteries on both sides. Once in position, tiny microspheres are injected into the arteries. These particles lodge in the small vessels and form clots that block blood flow to the prostate tissue.
Deprived of oxygen and nutrients, the targeted tissue undergoes cell death. Over the following days and weeks, the body breaks down and absorbs the dead tissue. The prostate shrinks, which reduces the physical compression on the urethra that causes difficulty urinating, weak stream, frequent urination, and nighttime bathroom trips.
What the Procedure Looks Like
PAE is done in a specialized radiology suite, not an operating room. You receive local anesthesia at the catheter insertion site and typically some form of sedation to keep you comfortable, but you stay awake. The radiologist uses real-time X-ray imaging to guide the catheter through your arterial system to the prostate. Several types of microspheres can be used as the blocking agent, all designed to permanently lodge in the small arteries.
The procedure generally takes one to three hours, depending on the complexity of your arterial anatomy. Once complete, the catheter is removed and a small bandage is placed at the access site. Most centers perform PAE as a same-day procedure, meaning you go home afterward. Unlike traditional prostate surgery, a urinary catheter is not always required, though some centers do place one temporarily.
Symptom Improvement
PAE produces meaningful relief for most patients. In one prospective study, the average symptom score dropped from 25.4 before the procedure to 9.1 at three months, a reduction of about 16 points on a 35-point scale. At 12 months, symptom scores remained significantly lower than baseline, averaging 11.9. To put that in practical terms, men went from severe urinary symptoms to mild ones.
Improvement isn’t instant. Some patients notice changes within the first week or two, but full benefit typically develops over one to three months as the prostate gradually shrinks.
How PAE Compares to Surgery
The standard surgical treatment for BPH is transurethral resection of the prostate (TURP), where tissue is physically removed through the urethra. TURP tends to produce somewhat greater improvement in urinary flow rate and symptom scores. In one head-to-head comparison, TURP achieved an 18-point symptom score improvement at six months compared to 14 points for PAE. Urine flow improvements were also larger after TURP.
Where PAE holds clear advantages is in the experience surrounding the procedure. There’s no general anesthesia, no surgical incision, significantly less blood loss, and a dramatically faster recovery. Most PAE patients resume normal activities the following day, while TURP requires a hospital stay and catheter use for several days. PAE also avoids some of the surgical risks associated with TURP, including a substantially lower rate of retrograde ejaculation.
Sexual Side Effects
Sexual function is one of the biggest concerns for men considering any prostate procedure, and it’s where PAE has a notable advantage over surgery. TURP causes retrograde ejaculation (where semen goes into the bladder instead of out) in roughly 50 to 70% of patients. After PAE, meta-analyses estimate the risk of retrograde ejaculation at 0 to 2.3%, though one randomized trial found higher rates when all degrees of ejaculatory change were counted: about 16% of PAE patients experienced complete loss of ejaculation, and 40% noticed reduced ejaculate volume.
Erectile function is generally preserved after PAE. Some studies have actually found slight improvements in erectile function scores after the procedure, possibly because relieving severe urinary symptoms improves overall quality of life and sexual confidence. Temporary blood in the semen occurs in about 16% of patients but resolves on its own.
Recovery and What to Expect Afterward
The most common side effect is post-embolization syndrome, which occurs in roughly 25% of patients. It’s a temporary reaction to the tissue dying off inside the prostate, and it can include urinary burning or discomfort (about 22% of patients), pelvic or perineal pain (about 20%), brief worsening of urinary symptoms, low-grade fever, and occasionally nausea. These symptoms typically appear within the first few days and resolve within a week. Men with larger prostates (over 80 cubic centimeters) may experience more pronounced burning.
Most patients manage any discomfort with over-the-counter pain medication. The recovery timeline is one of PAE’s strongest selling points: most people return to work and normal physical activity the next day.
Long-Term Durability
PAE’s durability is its most significant limitation. The prostate can regrow or symptoms can return over time, and a meaningful percentage of patients eventually need a second procedure. Reintervention rates climb steadily: about 3% at one year, 16 to 18% at two to four years, and roughly 21% at five years. By eight to ten years, the reintervention rate can reach 40 to 58%, depending on the study.
This means PAE works well as a medium-term solution and may be ideal for men who want to delay or avoid surgery, but it may not be a permanent fix for everyone. Some men get a decade or more of relief, while others may eventually opt for TURP or another surgical approach if symptoms return.
Who Is a Good Candidate
PAE is now included in the American Urological Association’s guidelines for managing BPH, reflecting growing acceptance of the procedure. It’s generally offered to men with moderate to severe lower urinary tract symptoms from BPH who haven’t responded well enough to medications or who want to avoid the risks of surgery.
PAE is particularly appealing for men who prioritize preserving sexual function, those who can’t undergo general anesthesia due to other health conditions, and those who need a fast return to daily life. It can treat a wide range of prostate sizes, and larger prostates that might make TURP more complex can still be treated with PAE. Men on blood thinners may also find PAE preferable since it involves less bleeding risk than surgery.
The procedure is performed by interventional radiologists rather than urologists, so getting evaluated for PAE typically involves a referral to an interventional radiology practice, often at an academic medical center or a facility that specializes in vascular procedures.